Gastric Disease
Products Related to Gastric Disease(94)
- GC49692Tofacitinib-d3 (citrate)Purity: >99.00%
An internal standard for the quantification of tofacitinib
- GC49876Pantoprazole N-oxideCAS: 953787-60-5Purity: >95.00%
A potential impurity found in bulk preparations of pantoprazole
- GC52119Lansoprazole sulfone N-oxideCAS: 953787-54-7Purity: >98.00%
A potential impurity found in commercial preparations of lansoprazole
- GC52180WAY-169916CAS: 669764-18-5Purity: >98.00%
WAY-169916 is a pathway-selective ligand of ER (estrogen receptor) that acts by inhibiting NF-kB transcriptional activity.
- GC52283L-Cysteine-15N-d3CAS: 1795787-05-1Purity: >99.00%
An internal standard for the quantification of L-cysteine
- GC52384NFAT Inhibitor (cell-permeable) (trifluoroacetate salt)Purity: >95.00%
A cell-permeable form of NFAT inhibitor
- GC524135-Aminosalicylic Acid-d7Purity: >99.00%
An internal standard for the quantification of 5-aminosalicylic acid
- GC91406UK 122 (trifluoroacetate salt)CAS: 1186653-73-5Purity: >95.00%
UK 122 is an inhibitor of urokinase-type plasminogen activator (uPA; IC50 = 0.2 µM).
- GC91449Ipamorelin (acetate)Purity: >98.00%
Ipamorelin is a pentapeptide growth hormone secretagogue (GHS) and GHS receptor 1a (GHS-R1a) agonist.
- GC91909Fenoprofen-13C6 (sodium salt hydrate)CAS: 2687960-29-6Purity: >98.00%
Fenoprofen-13C6 is intended for use as an internal standard for the quantification of fenoprofen by GC- or LC-MS.
- GC91985Alloisolithocholic Acid-d4CAS: 2410277-60-8Purity: >99.00%
Alloisolithocholic acid-d4 is intended for use as an internal standard for the quantification of alloisolithocholic acid by GC- or LC-MS.
- GC91986Allolithocholic Acid-d4Purity: >99.00%
Allolithocholic acid-d4 is intended for use as an internal standard for the quantification of allolithocholic acid by GC- or LC-MS.
- GC92130Elsiglutide (acetate)Purity: >95.00%
Elsiglutide is a peptide derivative of glucagon-like peptide 2 (GLP-2).
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC49676 | 6β-hydroxy Budesonide | - | >95.00% | |
A metabolite of budesonide | ||||
| GC49692 | Tofacitinib-d3 (citrate) | - | >99.00% | |
An internal standard for the quantification of tofacitinib | ||||
| GC49780 | Omeprazole N-oxide | 176219-04-8 | >98.00% | |
A metabolite of omeprazole | ||||
| GC49849 | 3-Aminosalicylic Acid | 570-23-0 | >98.00% | |
A salicylic acid derivative | ||||
| GC49876 | Pantoprazole N-oxide | 953787-60-5 | >95.00% | |
A potential impurity found in bulk preparations of pantoprazole | ||||
| GC52119 | Lansoprazole sulfone N-oxide | 953787-54-7 | >98.00% | |
A potential impurity found in commercial preparations of lansoprazole | ||||
| GC52133 | 12-Tridecenoic Acid | 6006-06-0 | >95.00% | |
| GC52180 | WAY-169916 | 669764-18-5 | >98.00% | |
WAY-169916 is a pathway-selective ligand of ER (estrogen receptor) that acts by inhibiting NF-kB transcriptional activity. | ||||
| GC52283 | L-Cysteine-15N-d3 | 1795787-05-1 | >99.00% | |
An internal standard for the quantification of L-cysteine | ||||
| GC52378 | Cecropin A (trifluoroacetate salt) | - | >95.00% | |
An antimicrobial peptide | ||||
| GC52384 | NFAT Inhibitor (cell-permeable) (trifluoroacetate salt) | - | >95.00% | |
A cell-permeable form of NFAT inhibitor | ||||
| GC52413 | 5-Aminosalicylic Acid-d7 | - | >99.00% | |
An internal standard for the quantification of 5-aminosalicylic acid | ||||
| GC90630 | CRAMP (140-173) (mouse) (trifluoroacetate salt) | - | >98.00% | |
An antimicrobial peptide | ||||
| GC90701 | CAY10795 | 2241676-74-2 | >98.00% | |
A 15-PGDH inhibitor | ||||
| GC91083 | Tiopronin-Cysteine Disulfide | 77591-18-5 | >95.00% | |
A metabolite of tiopronin | ||||
| GC91406 | UK 122 (trifluoroacetate salt) | 1186653-73-5 | >95.00% | |
UK 122 is an inhibitor of urokinase-type plasminogen activator (uPA; IC50 = 0.2 µM). | ||||
| GC91449 | Ipamorelin (acetate) | - | >98.00% | |
Ipamorelin is a pentapeptide growth hormone secretagogue (GHS) and GHS receptor 1a (GHS-R1a) agonist. | ||||
| GC91909 | Fenoprofen-13C6 (sodium salt hydrate) | 2687960-29-6 | >98.00% | |
Fenoprofen-13C6 is intended for use as an internal standard for the quantification of fenoprofen by GC- or LC-MS. | ||||
| GC91913 | NS 3861 | 216853-59-7 | >98.00% | |
NS 3861 is a neuronal nicotinic acetylcholine receptor (nAChR) agonist. | ||||
| GC91985 | Alloisolithocholic Acid-d4 | 2410277-60-8 | >99.00% | |
Alloisolithocholic acid-d4 is intended for use as an internal standard for the quantification of alloisolithocholic acid by GC- or LC-MS. | ||||
| GC91986 | Allolithocholic Acid-d4 | - | >99.00% | |
Allolithocholic acid-d4 is intended for use as an internal standard for the quantification of allolithocholic acid by GC- or LC-MS. | ||||
| GC92130 | Elsiglutide (acetate) | - | >95.00% | |
Elsiglutide is a peptide derivative of glucagon-like peptide 2 (GLP-2). | ||||